Related Experiment Video
Updated: May 11, 2026

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
Mitral Valve Replacement in Infants and Children: Five-Year Outcomes of the HALO Clinical Trial
Fawwaz R Shaw1, Brian Kogon2, Jonathan Chen3
1Department of Cardiothoracic Surgery, Children's Healthcare of Atlanta/Emory University, Atlanta, Georgia.
Insights
Mitral valve replacement in infants using the 15-mm St Jude mechanical valve showed acceptable hemodynamics but carried significant risks. Avoid low-molecular-weight heparin for anticoagulation in pediatric patients, as valve replacement is often necessary.
Area of Science:
- Cardiology
- Pediatric Cardiac Surgery
- Biomedical Engineering
Background:
- Mitral valve disease in children often necessitates surgical intervention.
- While repair is preferred, mitral valve replacement (MVR) is sometimes required for pediatric patients.
- This study evaluates the 15-mm St Jude mechanical mitral valve in a pediatric population.
Purpose of the Study:
- To assess the safety and efficacy of the 15-mm St Jude mechanical mitral valve in pediatric patients undergoing MVR.
- To report outcomes including mortality, complications, and reinterventions in this cohort.
- To provide insights into anticoagulation strategies for pediatric MVR patients.
Main Methods:
- A multi-institutional Investigational Device Exemption trial.
- 23 children (mean age 7.8 months) received the 15-mm St Jude mechanical mitral valve.
- 100% complete follow-up was achieved for all patients.
Main Results:
- The 15-mm St Jude mechanical mitral valve demonstrated satisfactory hemodynamics in small children.
- The 1- and 5-year freedom from death or valve explantation was 71.0%.
- Complications included 6 deaths (all within 12 months, none valve-related), 4 pacemaker insertions, 3 thromboses requiring explantation, and 5 bleeding events.
Conclusions:
- The 15-mm St Jude mechanical mitral valve offers satisfactory hemodynamics for pediatric MVR.
- Mortality and complication rates in this high-risk pediatric group are significant.
- Low-molecular-weight heparin should be avoided as primary anticoagulation; eventual valve replacement is likely.
Background:
Repair is preferable for children with mitral valve disease, but mitral valve replacement (MVR) is occasionally necessary. This report presents the results of a multiinstitutional Investigational Device Exemption trial of the 15-mm St Jude (SJM) mechanical mitral valve (Abbott Structural Heart).
Methods:
From May 2015 to March 2017, 23 children aged 0.4 to 27.4 months (mean, 7.8 months; 85% <1 year) weighing 2.9 to 10.9 kg (mean, 5.5 kg) at 15 centers underwent MVR with a 15-mm SJM mechanical mitral valve (intraannular, 45%; supraannular, 55%). A total of 21 (91%) of the children had undergone previous cardiac operations. Follow-up until death, valve explantation, or 5 years postoperatively was 100% complete.
Results:
There were 6 deaths, all in the first 12 months; no death was valve related. Four patients required a pacemaker (2 supraannular, 2 intraannular). Three patients had thrombosis requiring valve explantation at 13, 21, and 35 days postoperatively. Two of these 3 patients were receiving low-molecular-weight heparin for anticoagulation, and the third had factor V Leiden deficiency. There were 5 nonfatal bleeding complications within 4 months of MVR (1-year freedom from bleeding, 71.0%). The 1- and 5-year freedom from death or valve explantation was 71.0%.
Conclusions:
In small children with severe mitral valve disease requiring MVR, the 15-mm SJM mechanical mitral valve provides satisfactory hemodynamics. Mortality and complications in these patients are not trivial. Low-molecular-weight heparin likely should be avoided as primary anticoagulation. Eventual valve replacement is inevitable.
Related Concept Videos
Mitral Valve Prolapse I: Introduction
Mitral Valve Prolapse II: Assessment and Management
Mitral Regurgitation III: Medical Management
Mitral Stenosis I: Introduction
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral Stenosis III: Medical Management

